| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064022A2 Leafy cotyledon1 genes and their uses |
| 09/07/2001 | WO2001064020A1 Method for producing somatic embryos of scots pine (p. sylvestris) |
| 09/07/2001 | WO2001055440A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055329A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055306A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001032898A3 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 09/07/2001 | WO2001016362A3 Fatty acid desaturase gene from plants |
| 09/07/2001 | WO2001016294A3 Metal binding compounds and their use in cell culture medium compositions |
| 09/07/2001 | WO2001016289A3 Zymogen activation system |
| 09/07/2001 | WO2001005956A3 Sialyation of n-linked glycoproteins in the baculovirus expression vector system |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000078119A3 Cardiomyocytes with enhanced proliferative potential |
| 09/07/2001 | WO2000050580B1 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 09/07/2001 | WO2000047618A3 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 09/07/2001 | WO2000046407A9 Methods of utilizing the tt virus |
| 09/07/2001 | WO2000046383A3 Method of modulating metabolite biosynthesis in recombinant cells |
| 09/07/2001 | WO2000002912A3 Disintegrin homologs |
| 09/07/2001 | CA2437495A1 Method for producing somatic embryos of scots pine (p. sylvestris) |
| 09/07/2001 | CA2401741A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | CA2401716A1 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | CA2401683A1 Design and discovery of protein based tnf-.alpha. variants for the treatment of tnf-.alpha. related disorders |
| 09/07/2001 | CA2401670A1 Human enzyme molecules |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401603A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | CA2401544A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | CA2401533A1 Tcf responsive element |
| 09/07/2001 | CA2401495A1 Methods and compositions to reduce or eliminate transmission of a transgene |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2400376A1 Methods for detection and treatment of neural cancers |
| 09/07/2001 | CA2399886A1 Leafy cotyledon1 genes and their uses |
| 09/07/2001 | CA2397502A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/06/2001 | US20010019841 Medium and matrix for long-term proliferation of cells |
| 09/06/2001 | US20010019840 Active retinoic acid-free culture medium for avian totipotent embryonic cells |
| 09/06/2001 | US20010019723 Complexing polynucleotide and polymer |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | DE10107360A1 Novel metalloprotease containing a thrombospondin domain (MPTS protein) is useful to treat aggrecan associated disease including rheumatoid arthritis and osteoarthritis |
| 09/06/2001 | DE10009341A1 Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten A method for antigen-specific stimulation of T lymphocytes |
| 09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
| 09/05/2001 | EP1130110A2 Assay for evaluating inhibition of cyclooxygenase-2 |
| 09/05/2001 | EP1130098A2 Mammalian osteoregulins |
| 09/05/2001 | EP1130093A1 Oligonucleotide mediated nucleic acid recombination |
| 09/05/2001 | EP1130088A1 Hybrid cell vaccines |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130086A1 Genetically engineered keratinocytes and toxicity assay using said keratinocytes |
| 09/05/2001 | EP1130030A1 Human erythroid differentiation related factor |
| 09/05/2001 | EP1129728A1 Methods and compositions for the selective modification of nucleic acids |
| 09/05/2001 | EP1129721A2 The use of isolated domains of type IV collagen to modify cell and tissue interactions |
| 09/05/2001 | EP1129617A1 Method of fertilizing an avian egg in the shell |
| 09/05/2001 | EP1129205A1 Transfection of male germ cells for generation of selectable transgenic stem cells |
| 09/05/2001 | EP1129204A1 Novel system for regulating transgene expression |
| 09/05/2001 | EP1129202A2 Chlamydia antigenes and corresponding dna fragments and uses thereof |
| 09/05/2001 | EP1129200A2 Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
| 09/05/2001 | EP1129199A2 Cell signaling polypeptides and nucleic acids |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129194A2 Interleukin-1 homolog zil1a4 |
| 09/05/2001 | EP1129193A1 Chemokine beta-7 |
| 09/05/2001 | EP1129191A1 Methods of diagnosing or treating neurological diseases |
| 09/05/2001 | EP1129190A1 Human tslp dna and polypeptides |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129188A1 Pge synthase and methods and means for modulating its activity |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129182A1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129179A1 Udp-galactose: beta-i(n)-acetyl-glucosamine beta1,3galactosyltransferases, beta3gal-t5 |
| 09/05/2001 | EP1129178A1 A sensitive screening system for envelope-defective recombinant virus |
| 09/05/2001 | EP1129176A1 Embryonic stem cells |
| 09/05/2001 | EP1129175A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 09/05/2001 | EP1129112A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129105A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey |
| 09/05/2001 | EP1129104A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey |
| 09/05/2001 | EP1129103A1 G protein-coupled receptor resembling the leukotriene b4 receptor |
| 09/05/2001 | EP1129064A1 Transfection reagents |
| 09/05/2001 | EP1128838A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 09/05/2001 | EP1128836A2 In utero transplantation of human mesenchymal stem cells |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP0964927A4 Cassava vein mosaic virus promoters and uses thereof |
| 09/05/2001 | EP0815213A4 An immortalized mammal hybridoma fusion partner |
| 09/05/2001 | EP0642326B1 Non-fibrogenic, alginate-coated transplants, process of manufacture and method of use thereof |
| 09/05/2001 | CN1311822A Gene therapy method |
| 09/05/2001 | CN1311820A BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses |
| 09/05/2001 | CN1311817A Modification of cereal grain hardness via expression of puroindoline proteins |
| 09/05/2001 | CN1311816A Genes coding for tomato beta-galactosidase polypeptides |
| 09/05/2001 | CN1311691A Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/05/2001 | CN1311437A Method for detection of specific antigen reaction of lymphocyte in blood |
| 09/05/2001 | CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 09/05/2001 | CN1070611C Hybridoma cell lines and thier monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/05/2001 | CN1070533C yeast agglutination genes and yeast contg. same |
| 09/04/2001 | US6284952 Transgenic plants with divergent [ScaM4 or] SCaM5 gene to achieve multiple disease resistance |
| 09/04/2001 | US6284949 A chimeric plant gene having a promoter for rna production, a dna sequence with insecticidally activity and a 3' non-translated dna sequence which causes polyadenylation of the rna; producing insect resistant plants |
| 09/04/2001 | US6284946 Banana DNA associated with fruit development |
| 09/04/2001 | US6284945 Zea mays (L.) with capability of long term, highly efficient plant regeneration including fertile transgenic maize plants having a heterologous gene, and their preparation |